Table 17:

Results of Economic Literature Review—Summary

Name, Year, Location	Study Design and Perspective	Populations	Interventions	Results
				Health Outcomes	Costs
Craig et al, 2013,43 United Kingdom	Cost-consequence analysis (cost per patient) Decision-tree model NHS Borders perspective	Patients at high risk of ulceration (preventative cohort; n = 508) Patients with a foot ulcer (curative cohort; n = 178) Mean age 77 (± 12.1) years	Intervention: Soft-heel casting Comparator: Orthotic footwear	Preventative pathway Soft-heel casting: no ulcer 84%; new foot ulcer 16% Orthotic footwear: no ulcer 82%; new foot ulcer 18% Curative pathway Inpatients ∘Soft-heel casting: healed ulcer 44%; improved ulcer 22%; amputation 6%; death 28% ∘Orthotic footwear: healed ulcer 42%; improved ulcer 21%; amputation 5%; death 32% Outpatients ∘Soft-heel casting: healed ulcer 50%; improved ulcer 27%; amputation 7%; death 16% ∘Orthotic footwear: healed ulcer 48%; improved ulcer 26%; amputation 8%; death 18%	2013 British pounds Expected costs per patient ∘Preventative pathway: soft-heel casting £1,637; orthotic footwear £1,413 ∘Curative pathway: Inpatients: soft-heel casting £7,540; orthotic footwear £6,991 Outpatients: soft-heel casting £5,977; orthotic footwear £5,359

Abbreviations: NHS, National Health Service.